Neoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Gálvez Montón, Carolina ^a   Fernandez Figueras, M Teresa ^b,c   Martí, Mercè ^c,d   Soler Botija, Carolina ^a   Roura, Santiago ^a   Perea Gil, Isaac ^a   Prat Vidal, Cristina ^a   Llucià Valldeperas, Aida ^a   Raya, Ángel ^c,d,e   Bayes Genis, Antoni ^a,b,f  

^a FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c CENTER OF REGENERATIVE MEDICINE IN BARCELONA   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^e INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; BETA3 TUBULIN; CD31 ANTIGEN; ELASTIN ANTIBODY; ISOLECTIN B4; PROTEIN ANTIBODY; PROTEIN S 100; SMOOTH MUSCLE ACTIN; TROPONIN I; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; TUBULIN;

ACELLULAR PERICARDIAL DERIVED SCAFFOLD; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC IMPLANT; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; HEART; HEART ENDDIASTOLIC VOLUME; HEART ENDDIASTOLIC WALL MASS; HEART ENDSYSTOLIC VOLUME; HEART INFARCTION; HEART INFARCTION SIZE; HEART INNERVATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART STROKE VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; NERVE ENDING; NERVE FIBER; NONHUMAN; NONMYELINATED NERVE; NUCLEAR MAGNETIC RESONANCE IMAGING; PIG; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSORY NERVE; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; ANIMAL; CARDIAC MUSCLE; CORONARY BLOOD VESSEL; CYTOLOGY; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MYOCARDIAL INFARCTION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PERICARDIUM; PHYSIOLOGY; TISSUE SCAFFOLD; TRANSPLANTATION;

ANIMALIA; SUIDAE;

ANIMALS; CORONARY VESSELS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; PERICARDIUM; S100 PROTEINS; SWINE; TISSUE SCAFFOLDS; TUBULIN; VENTRICULAR FUNCTION, LEFT;

EID: 84938680393     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-015-0101-6     Document Type: Article

References (20)

1. Gálvez-Montón C, Ordoñez-Llanos J, Bayes-Genis A, Bayes de Luna A. One hundred years of myocardial infarction: where we have come from and where we are going. Eur Heart J. 2012;33:2883-91.
2. Gálvez-Montón C, Prat-Vidal C, Roura S, Soler-Botija C, Bayes-Genis A. Cardiac tissue engineering and the bioartificial heart. Rev Esp Cardiol. 2013;66:391-9.
3. Vunjak-Novakovic G, Lui KO, Tandon N, Chien KR. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Pev Biomed Eng. 2011;13:245-67.
4. Fu XM, Lee JK, Miwa K, Shimizu T, Takagishi Y, Hirabayashi M, et al. Sympathetic innervation induced in engrafted engineered cardiomyocyte sheets by glial cell line derived neurotrophic factor in vivo. Biomed Res Int. 2013;2013:532720.
5. Prat-Vidal C, Gálvez-Montón C, Puig-Sanvicens V, Sanchez B, Díaz-Güemes I, Bogonez-Franco P, et al. Online monitoring of myocardial bioprosthesis for cardiac repair. Int J Cardiol. 2014;174:654-61.
6. Wang B, Williams LN, de Jongh Curry AL, Liao J. Preparation of acellular myocardial scaffolds with well-preserved cardiomyocyte lacunae, and method for applying mechanical and electrical simulation to tissue construct. Methods Mol Biol. 2014;1181:189-202.
7. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004;36:1031-7.
8. Reis LA, Chiu LL, Feric N, Fu L, Radisic M. Biomaterials in myocardial tissue engineering. J Tissue Eng Regen Med. 2014;doi: 10.1002/term.1944.
9. Ingber DE. Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circ Res. 2002;91:877-87.
10. Muylaert DE, Fledderus JO, Bouten CV, Dankers PY, Verhaar MC. Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds. Heart. 2014;100:1825-30.
11. Singelyn JM, Christman KL. Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices. J Cardiovasc Transl Res. 2010;3:478-86.
12. Remppis A, Pleger ST, Most P, Lindenkamp J, Ehlermann P, Schweda C, et al. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. J Gene Med. 2004;6:387-94.
13. Duarte-Costa S, Castro-Ferreira R, Neves JS, Leite-Moreira AF. S100A1: a major player in cardiovascular performance. Physiol Res. 2014;63:669-81.
14. Rohde D, Ritterhoff J, Voelkers M, Katus HA, Parker TG, Most P. S100A1: a multifaceted therapeutic target in cardiovascular disease. J Cardiovasc Transl Res. 2010;3:525-37.
15. Heizmann CW, Fritz G, Schäfer BW. S100 proteins: structure, functions and pathology. Front Biosci. 2002;7:d1356-68.
16. Tong L, Ji L, Wang Z, Tong X, Zhang L, Sun X. Differentiation of neural stem cells into Schwann-like cells in vitro. Biochem Biophys Res Commun. 2010;401:592-7.
17. Bordji K, Grandval A, Cuhna-Alves L, Lechapt-Zalcman E, Bernaudin M. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells. FEBS J. 2014;281:5220-36.
18. Katsetos CD, Dráberová E, Legido A, Dumontet C, Dráber P. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin. J Cell Physiol. 2009;221:505-13.
19. Aly H, Mohsen L, Badrawi N, Gabr H, Ali Z, Akmal D. Viability and neural differentiation of mesenchymal stem cells derived from the umbilical cord following perinatal asphyxia. J Perinatol. 2012;32:671-6.
20. Van Stee EW. Autonomic innervation of the heart. Environ Health Perspect. 1978;26:151-8.